United States Biotechnology & Medical Research

Parabilis Medicines Inc (PBLS)

Track

Parabilis Medicines Inc. witnessed significant buying activity over the past ninety days, totaling over 441 million dollars across fourteen transactions. Three distinct insiders, including RA Capital Management, L.P., acquired shares during this period. These purchases occurred while the stock price traded near its fifty-two-week high, reflecting a 12.6 percent increase recently.
Ticker: PBLS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Parabilis Medicines Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 22 Jul 2026
Value US$4,831,817.90 | Price 373.30 | Shares 54,786 (-7.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-22 2026-07-22 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
54,786 -7.0%
373.30
US$4,831,818 		54,786 -7.0% 373.30 US$4,831,818
2026-07-22 2026-07-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
2,976 +5.0%
334.12
US$377,320 		2,976 +5.0% 334.12 US$377,320
2026-07-22 2026-07-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
80,351 -30.2%
219.71
US$1,261,482 		80,351 -30.2% 219.71 US$1,261,482
2026-07-22 2026-07-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,000 +0.1%
27.96
US$100,000 		1,000 +0.1% 27.96 US$100,000
2026-07-22 2026-07-20 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,000 +0.1%
27.72
US$100,000 		1,000 +0.1% 27.72 US$100,000
2026-07-22 2026-07-20 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,000 +0.4%
27.13
US$100,000 		1,000 +0.4% 27.13 US$100,000
2026-06-16 2026-06-15 B Purchase
SEBULSKY ALAN
Non-Executive Director
4,065 +15.7%
27.10
US$110,146 		4,065 +15.7% 27.10 US$110,146
2026-06-16 2026-06-15 B Purchase
SEBULSKY ALAN
Non-Executive Director
5,000 +23.9%
26.00
US$129,989 		5,000 +23.9% 26.00 US$129,989
2026-06-16 2026-06-12 B Purchase
SEBULSKY ALAN
Non-Executive Director
8,435 +67.5%
27.67
US$233,393 		8,435 +67.5% 27.67 US$233,393
2026-06-29 2026-06-11 B Purchase
2.3
Levy Guy
Large shareholder
125,000 +23.7%
20.00
US$2,500,000 		125,000 +23.7% 20.00 US$2,500,000
2026-06-29 2026-06-11 B Purchase
2.3
Levy Guy
Large shareholder
375,000 +57.5%
20.00
US$7,500,000 		375,000 +57.5% 20.00 US$7,500,000
2026-06-15 2026-06-11 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,460,397 +122.9%
20.00
US$29,207,940 		1,460,397 +122.9% 20.00 US$29,207,940
2026-06-15 2026-06-11 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
19,728,353 +300.9%
20.00
US$394,567,060 		19,728,353 +300.9% 20.00 US$394,567,060
2026-06-15 2026-06-11 B Purchase
SEBULSKY ALAN
Non-Executive Director
12,500 +inf%
20.00
US$250,000 		12,500 +inf% 20.00 US$250,000
Explore more

More insider trading research around Parabilis Medicines Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America